Medidata Opens Access to its Patient Insights Program

Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials

Medidata, a Dassault Systèmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for clinical trials.

Medidata will open access to its Patient Insights Program as part of a new offering to incorporate a patient-centric approach to the design and development of clinical trial protocols and technologies.

The Patient Insights Program provides access to Medidata’s experienced and diverse Patient Insights Board, using innovative workshops called design studios to guide the creation of protocols and patient-facing solutions to improve clinical trial experiences, expedite clinical trial delivery timelines, and bring therapies to market faster.

“Medidata is the first company to institute a formal process of infusing the patient perspective into the software development life cycle to create technical solutions improving the overall patient experience,” said Alicia Staley, vice president, Patient Engagement at Medidata. “We are opening up access to this program to ultimately make clinical trials an option for more people, including those historically left behind by clinical trials.”

“Patient centricity” has been a buzzword for nearly a decade but most clinical studies are designed with little to no direct input from the patients/caregivers that are expected to enroll in and adhere to a clinical research study. Patient engagement has mostly been limited to sporadic and superficial sessions, with little impact on reducing patient burden or improving enrollment, retention, and experience.

“Participating in a Patient Design Studio with Medidata’s patient advocates to co-create, edit and inform our Clinical Trial Readiness Tool was invaluable,” said Erin Miller, development manager/ IMPACT and PATH Program liaison for Lazarex Cancer Foundation. “This one-of-a-kind tool will help us understand each patient’s individual journey and allow us to get them the resources they need to successfully stay in their clinical trial, giving them hope and a chance for an improved cancer health outcome.”

The Medidata Patient Insights team has run over 20 design studios to provide feedback and insights into Medidata’s products. Medidata’s Patient Centricity by Design is a formal methodology by which the patient perspective is infused into the software development life cycle. This video shows how Medidata develops empathetic technical solutions by including patients in our work.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

SourceMedidata
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy